The present invention comprises a group of compounds that effectively inhibit angiogenesis. More specifically, thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products have been shown to inhibit angiogenesis and to treat disease states resulting from angiogenesis. Importantly, these compounds can be administered orally.

 
Web www.patentalert.com

< Inorganic particle-containing composition, transfer film comprising the same and plasma display panel production process

< Low temperature sanitization of human pathogens from the surfaces of food and food packaging

> Semiconductor memory device and portable electronic apparatus including the same

> Support for lithographic printing plate and presensitized plate
~ 00228